Sigachi Laboratories Unquoted Share Price

Sigachi Industries Limited share Price, Unlisted Shares, Pre IPO-Stock - Company Overview

Sigachi holds a prominent position in the Pharma Excipients, Nutra, and food ingredients industry. Established in 1989, it swiftly became one of the leading global manufacturers of Microcrystalline Cellulose. Operating from multiple locations in Telangana and Gujarat, Sigachi ensures a robust supply chain for its global clientele.

Sigachi's facilities boast certifications such as EXCiPACT GMP, SGMP, HACCP, EDQM CEP, and ISO 9001:2015, showcasing their commitment to quality. Renowned for reliability and quality, Sigachi serves customers across Asia, Australia, the Americas, Europe, and the Middle East. They continually innovate and deliver specialized products that cater to the evolving market needs.         

Sigachi Industries Share Price, Unlisted Share Details as of March 31, 2025

Sigachi Laboratories Limited Incorporation Details 

Board of Directors of Sigachi Industries Limited 

Sigachi Industries Limited Ltd Principal Business Activities

Sigachi Industries Company Limited's Particulars of Holding, Subsidiaries, & Associate Companies

Sigachi Industries Limited Shareholding Pattern (As of 31-03-2025)

FAQs on  Sigachi Laboratories Ltd 

Q: What is the face value of Sigachi Laboratories Ltd shares?

Answer: The face value of Sigachi Laboratories Ltd is ₹10 per equity share.

Q: What is the minimum lot size for buying Sigachi Laboratories shares through WWIPL?
Answer: The minimum lot size for Sigachi Laboratories shares is 100 equity shares.

Q: How can I buy Sigachi Laboratories unlisted shares through WWIPL?
Answer: Investors can complete the KYC process, confirm the transaction details with WWIPL, transfer funds, and receive shares directly in their Demat account.

Q: Why should I buy Sigachi Laboratories shares through WWIPL?
Answer: WWIPL offers transparent pricing, secure transactions, seamless Demat transfers, and dedicated support throughout the investment process.

Q: Is investing in Sigachi Laboratories Ltd a good idea?
Answer: Investors often evaluate Sigachi Laboratories based on its pharmaceutical manufacturing business, financial performance, operational efficiency, and long-term growth potential in the healthcare sector.

Q: Why do investors buy Sigachi Laboratories shares before a potential IPO?
Answer: Investors seek early exposure to a pharmaceutical company with the expectation of long-term value creation and potential liquidity through a future listing.

Q: What business does Sigachi Laboratories Ltd operate in?
Answer: Sigachi Laboratories is engaged in the manufacture of pharmaceuticals, medicinal chemicals, and botanical products, with pharmaceutical manufacturing being its principal business activity.

Q: Who founded Sigachi Laboratories Ltd?
Answer: Sigachi Laboratories was incorporated in 1994 as an Indian public limited company and operates in the pharmaceutical manufacturing sector.

Q: What makes Sigachi Laboratories different from other unlisted pharmaceutical companies?
Answer: Sigachi Laboratories focuses on pharmaceutical manufacturing and medicinal products, supported by an established operating history and a specialized presence in the pharma industry.

Q: What are the key growth drivers for Sigachi Laboratories Ltd?
Answer: Growth is supported by increasing demand for pharmaceutical products, manufacturing expansion, operational efficiency, product development, and opportunities within the healthcare sector.

Q: What factors affect the valuation of Sigachi Laboratories shares?
Answer: Revenue growth, profitability, manufacturing capabilities, financial performance, market demand for unlisted shares, and future listing prospects are important valuation drivers.

Q: Are Sigachi Laboratories shares available in Demat form?
Answer: Yes. Shares purchased through WWIPL are transferred directly to the investor's Demat account.

Q: Can I sell my Sigachi Laboratories shares through WWIPL?
Answer: Yes. WWIPL facilitates both buying and selling of unlisted shares, subject to market demand and share availability.

Q: What documents are required to buy Sigachi Laboratories shares through WWIPL?
Answer: Investors generally need PAN, Aadhaar, Client Master Report (CMR), and bank account details to complete the transaction.

Q: What are the risks of investing in Sigachi Laboratories shares?
Answer: Investors should consider regulatory risks, competition in the pharmaceutical industry, execution risks, profitability fluctuations, and liquidity constraints associated with unlisted shares.

Q: How does WWIPL help investors track Sigachi Laboratories investments?
Answer: WWIPL provides company updates, transaction assistance, market information, and investment insights to help investors stay informed.

Q: How long does it take for Sigachi Laboratories shares purchased through WWIPL to be credited to a Demat account?
Answer: Shares are generally transferred to the investor's Demat account after successful completion and verification of the transaction.

Q: What should investors evaluate before investing in Sigachi Laboratories Ltd?
Answer: Investors should assess the company's financial performance, manufacturing capabilities, profitability, valuation, competitive position, and long-term growth prospects.

Q: Can Sigachi Laboratories benefit from the growth of India's pharmaceutical industry?
Answer: Yes. Rising healthcare demand, increasing pharmaceutical consumption, expanding manufacturing opportunities, and growth in the domestic and global pharma markets may support the company's long-term growth.